DE60033447D1 - Optically pure camptothecin analogues - Google Patents

Optically pure camptothecin analogues

Info

Publication number
DE60033447D1
DE60033447D1 DE60033447T DE60033447T DE60033447D1 DE 60033447 D1 DE60033447 D1 DE 60033447D1 DE 60033447 T DE60033447 T DE 60033447T DE 60033447 T DE60033447 T DE 60033447T DE 60033447 D1 DE60033447 D1 DE 60033447D1
Authority
DE
Germany
Prior art keywords
optically pure
camptothecin analogues
pure camptothecin
analogues
optically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033447T
Other languages
German (de)
Other versions
DE60033447T2 (en
Inventor
Olivier Lavergne
Dennis Bigg
Christophe Lanco
Alain Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE60033447D1 publication Critical patent/DE60033447D1/en
Publication of DE60033447T2 publication Critical patent/DE60033447T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60033447T 1999-02-26 2000-02-24 Optically pure camptothecin analogues Expired - Lifetime DE60033447T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9902398A FR2790261B1 (en) 1999-02-26 1999-02-26 NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION
FR9902398 1999-02-26

Publications (2)

Publication Number Publication Date
DE60033447D1 true DE60033447D1 (en) 2007-03-29
DE60033447T2 DE60033447T2 (en) 2007-10-31

Family

ID=9542564

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60003170T Expired - Lifetime DE60003170T2 (en) 1999-02-26 2000-02-24 OPTICALLY PURE ANALOGS OF CAMPTOTHECINE
DE60033447T Expired - Lifetime DE60033447T2 (en) 1999-02-26 2000-02-24 Optically pure camptothecin analogues

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60003170T Expired - Lifetime DE60003170T2 (en) 1999-02-26 2000-02-24 OPTICALLY PURE ANALOGS OF CAMPTOTHECINE

Country Status (29)

Country Link
US (1) US7012079B1 (en)
EP (2) EP1338599B1 (en)
JP (1) JP2002537399A (en)
KR (1) KR20010108270A (en)
CN (1) CN1195757C (en)
AR (1) AR022740A1 (en)
AT (2) ATE242248T1 (en)
AU (1) AU772632B2 (en)
BR (1) BR0008526A (en)
CA (1) CA2364705C (en)
CZ (1) CZ20013091A3 (en)
DE (2) DE60003170T2 (en)
DK (1) DK1165565T3 (en)
ES (2) ES2200829T3 (en)
FR (1) FR2790261B1 (en)
HK (1) HK1045514B (en)
HR (1) HRP20010622A2 (en)
HU (1) HUP0200529A3 (en)
IL (2) IL144987A0 (en)
MX (1) MXPA01008658A (en)
MY (1) MY127819A (en)
NO (1) NO327260B1 (en)
NZ (1) NZ514153A (en)
PL (1) PL202393B1 (en)
PT (1) PT1165565E (en)
RU (1) RU2230745C2 (en)
TW (1) TWI268931B (en)
WO (1) WO2000050427A1 (en)
ZA (1) ZA200107738B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
CN100408582C (en) * 2004-02-12 2008-08-06 中国人民解放军第二军医大学 Homocamptoth-ecine compounds, their preparation process and use
WO2006033011A1 (en) * 2004-09-21 2006-03-30 Societe De Conseils De Recherches Et D'applications Scientifique (S.C.R.A.S.) Novel processes for the production of useful intermediates
US8575484B1 (en) 2010-09-14 2013-11-05 Cooper Technologies Company Adjustable-depth ring assembly and method of installation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768431B1 (en) 1997-08-29 2000-03-24 Sod Conseils Rech Applic NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS, A NEW OPTICALLY PURE SYNTHESIS INTERMEDIATE AND PROCESS FOR PREPARING THE SAME
FR2757514B1 (en) 1996-12-20 1999-02-12 Sod Conseils Rech Applic NOVEL CAMPTOTHECIN ANALOGS, PREPARATION METHODS, USE THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RO117918B1 (en) * 1995-06-21 2002-09-30 Sod Conseils Rech Applic Camptothecin analogue compounds, process for preparing the same, intermediate product, pharmaceutical composition and use
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
FR2757515B1 (en) * 1996-12-20 2000-05-05 Sod Conseils Rech Applic PRODROUGAL FORMS AND NEW CAMPTOTHECIN ANALOGS, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9711319B1 (en) * 1996-08-19 2009-08-11 highly lipophilic camptothecin derivatives.
UA57757C2 (en) * 1996-12-20 2003-07-15 Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) FORMS OF PRODRUGS AND NEW ANALOGUES OF camptothecin, THEIR APPLICATION AS MEDICINES
CA2280905C (en) * 1997-02-14 2006-08-29 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
US6207673B1 (en) * 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof

Also Published As

Publication number Publication date
IL144987A (en) 2006-12-31
MY127819A (en) 2006-12-29
AU772632B2 (en) 2004-05-06
BR0008526A (en) 2002-01-08
DE60033447T2 (en) 2007-10-31
NO327260B1 (en) 2009-05-25
CN1345321A (en) 2002-04-17
HUP0200529A3 (en) 2004-03-29
HRP20010622A2 (en) 2002-08-31
HUP0200529A2 (en) 2002-06-29
US7012079B1 (en) 2006-03-14
ZA200107738B (en) 2003-02-26
EP1165565B1 (en) 2003-06-04
PT1165565E (en) 2003-10-31
HK1045514B (en) 2005-11-18
FR2790261B1 (en) 2004-09-10
AU2921000A (en) 2000-09-14
WO2000050427A1 (en) 2000-08-31
NZ514153A (en) 2001-09-28
ATE242248T1 (en) 2003-06-15
JP2002537399A (en) 2002-11-05
CA2364705C (en) 2010-03-30
AR022740A1 (en) 2002-09-04
DK1165565T3 (en) 2003-10-06
IL144987A0 (en) 2002-06-30
CN1195757C (en) 2005-04-06
CZ20013091A3 (en) 2002-05-15
KR20010108270A (en) 2001-12-07
ATE353902T1 (en) 2007-03-15
EP1338599A1 (en) 2003-08-27
HK1045514A1 (en) 2002-11-29
RU2230745C2 (en) 2004-06-20
NO20014117D0 (en) 2001-08-24
PL202393B1 (en) 2009-06-30
DE60003170D1 (en) 2003-07-10
TWI268931B (en) 2006-12-21
ES2200829T3 (en) 2004-03-16
EP1338599B1 (en) 2007-02-14
PL361334A1 (en) 2004-10-04
FR2790261A1 (en) 2000-09-01
EP1165565A1 (en) 2002-01-02
DE60003170T2 (en) 2004-04-01
CA2364705A1 (en) 2000-08-31
NO20014117L (en) 2001-10-11
MXPA01008658A (en) 2002-03-14
ES2282564T3 (en) 2007-10-16

Similar Documents

Publication Publication Date Title
DE60028324D1 (en) Optical rangefinder
DE59909421D1 (en) OPTOELECTRONIC CONSTRUCTION UNIT
DE60038769D1 (en) OPTOELECTRONIC COMPONENT
DK1235777T3 (en) Vitamin D analogues
EE200200150A (en) Preparation
DE60036662D1 (en) Elongated light
DE60022034D1 (en) LAST CONSTRUCTION
ID26898A (en) HYDROFILIC FIBER
DK1235824T3 (en) Vitamin D analogues
ATE353902T1 (en) OPTICALLY PURE CAMPTOTHECIN ANALOGUES
DE60045904D1 (en) Pasty-packaged optoelectronic component
DE29901468U1 (en) Decorative uplighter
NO20000645D0 (en) awning
DE50002350D1 (en) HELICOPTER
DE50002316D1 (en) skimmer
FI990619A0 (en) grave Light
DE29902811U1 (en) Decorative light
DE69936578D1 (en) Transparent status interface
DE60007598D1 (en) attachment structure
DE29903731U1 (en) railing
ES1043085Y (en) PLANOCONVEXA TILE
DE50006137D1 (en) awning
DE29903201U1 (en) Banisters
NO992248D0 (en) Railing
ATA51799A (en) OPTICAL VISIBILITY

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR